Alzheimer disease biomarker testing in cerebrospinal fluid: a method to harmonize assay platforms in the absence of an absolute reference standard

Clin Chem. 2013 Apr;59(4):710-2. doi: 10.1373/clinchem.2012.201830. Epub 2013 Jan 25.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease / cerebrospinal fluid
  • Alzheimer Disease / diagnosis*
  • Amyloid beta-Peptides / cerebrospinal fluid*
  • Enzyme-Linked Immunosorbent Assay
  • Humans
  • Peptide Fragments / cerebrospinal fluid*
  • Reference Standards

Substances

  • Amyloid beta-Peptides
  • Peptide Fragments
  • amyloid beta-protein (1-42)